name:-0.0069668292999268
name:-0.0028021335601807
name:-0.003882884979248
VelosBio Inc. Patent Filings

VelosBio Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for VelosBio Inc..The latest application filed is for "anti-ror1 / anti-cd3 bispecific binding molecules".

Company Profile
6.2.10
  • VelosBio Inc. - Rahway NJ
  • VelosBio Inc. - San Diego CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Anti-ror1 / Anti-cd3 Bispecific Binding Molecules
App 20220227866 - Watkins; Jeffry D. ;   et al.
2022-07-21
Cancer Treatment With Ror1 Antibody Immunoconjugates
App 20220152214 - Miller; Langdon ;   et al.
2022-05-19
Ror1 Antibody Immunoconjugates
App 20220133901 - Lannutti; Brian ;   et al.
2022-05-05
ROR1 Antibody Immunoconjugates
App 20200030454 - Lannutti; Brian ;   et al.
2020-01-30
ROR1 antibody immunoconjugates
Grant 10,335,496 - Lannutti , et al.
2019-07-02
ROR1 Antibody Immunoconjugates
App 20180369406 - Lannutti; Brian ;   et al.
2018-12-27
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed